Everest Organics Ltd.
Snapshot View

125.60 +0.35 ▲0.3%

02 December 2022, 04:01:00 PM
Volume: 2,960

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.everestorganicsltd.com
Market Cap 100.48 Cr.
Enterprise Value(EV) 140.11 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -1.83 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.40 Trailing Twelve Months Ending 2022-09
Book Value / Share 55.73 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.25 Calculated using Price: 125.60
Dividend Yield 0.40 Period Ending 2022-03
No. of Shares Subscribed 0.80 Cr. 8,000,000 Shares
FaceValue 10
Company Profile
The company's facilities comply to GMP standards and is certified by the Drug Control Authority of the Government of Andhra Pradesh, India. It supply products to major multinational companies abroad, prominent well established formulation companies in India, Europe, USA, Far East and the Middle East, and also to Latin / Central / South American Countries. The company also provides adequate technical & documentary support for their products and its products comply to various pharmacopial standards like BP, USP, EP and IP Standards as desired by the customer.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.28%
1 Week
-0.44%
1 Month
-2.14%
3 Month
-4.27%
6 Month
-15.51%
1 Year
-53.72%
2 Year
-52.14%
5 Year
-9.22%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 23.31 33.19 3.06 12.25 9.86 33.63 36.22 33.96 2.45
Return on Capital Employed (%) 13.82 15.84 8.90 13.55 13.80 35.30 35.22 33.76 6.25
Return on Assets (%) 1.42 2.50 0.25 1.67 1.90 7.45 9.58 10.73 0.73

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4 6 6 16 19 26 34 47 47 45
Non Curr. Liab. 10 11 14 7 8 10 12 11 19 20
Curr. Liab. 51 50 56 63 67 71 74 77 113 128
Minority Int.
Equity & Liab. 65 67 76 86 94 107 120 135 178 193
Non Curr. Assets 25 25 29 37 36 40 41 46 60 64
Curr. Assets 41 42 47 49 58 67 79 89 118 129
Misc. Exp. not W/O
Total Assets 65 67 76 86 94 107 120 135 178 193

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 96 106 99 107 112 156 167 182 200 191
Other Income 1 1 1 1 1 1 1 1 2 1
Total Income 97 107 100 108 113 156 169 183 202 192
Total Expenditure -91 -98 -94 -101 -105 -138 -148 -159 -194 -186
PBIDT 6 8 6 7 8 18 21 24 9 6
Interest -3 -3 -3 -3 -3 -3 -3 -3 -3 -3
Depreciation -2 -3 -3 -2 -3 -3 -3 -3 -4 -4
Taxation 0 0 0 0 -1 -5 -3 -4 -1 0
Exceptional Items -1 -1
PAT 1 2 0 1 2 8 11 14 1 -1
Adjusted EPS 1 2 1 2 2 9 14 17 1 -2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 7 1 4 7 10 5 9 10 14 14
Cash Fr. Inv. -4 -3 -3 -7 -8 -4 -5 -6 -12 -17
Cash Fr. Finan. -3 2 -2 0 -2 0 -3 -3 -2 2
Net Change 0 0 0 0 0 1 1 0 0 -1
Cash & Cash Eqvt 1 1 1 1 1 1 2 2 2 1

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 73.79 74.04 74.15 74.15 74.15 74.15 74.15 74.15 74.15
Public 26.21 25.96 25.85 25.85 25.85 25.85 25.85 25.85 25.85
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 18 Nov 2022
Disclosure Of Related Party Transactions For The Half Year Ended September 30 2022
Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the applicable disclosure on Related Party Transactions for the half year ended September 30 2022 in the requisite format.
Sat, 12 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to the captioned subject and pursuant to Regulation 47 of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 we hereby inform you that the Company has published the Un-Audited Financial Results of the Company for the second quarter and half year ended September 30 2022 approved by the Board of Directors at its Meeting held on Friday November 11 2022 in Financial Express (English Newspaper) and Nava Telangana (Telugu Newspaper) on 12.11.2022. The said publication is enclosed herewith.
Fri, 11 Nov 2022
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2022
Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we are enclosing herewith the Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2022 as approved by the Board of Directors at their meeting held on November 11 2022 along with Limited Review Report issued by the Statutory Auditors M/s. P. S. N. Ravishanker & Associates Chartered Accountant Hyderabad.

The Board Meeting commenced at 10:00 am and concluded at 12:55 pm.

Technical Scans View Details >>

Fri, 02 Dec 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Year High Decrease 1 Year
High Decrease 2 Years High Decrease 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,530.84 1,040.00 -0.6%
Cipla Ltd. 89,936.23 1,114.35 -0.9%
Divi's Laboratories Ltd. 89,761.56 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. 75,098.21 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. 70,043.98 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. 54,931.39 1,623.05 -1.2%
Max Healthcare Institute Ltd. 43,491.25 448.10 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 35.23 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.99 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 24.23 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 83.18 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.92 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 46.09 448.10 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 4.13 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.40 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.63 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.67 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.02 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.29 448.10 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 448.10 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 448.10 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 448.10 -0.9%

FAQ's On Everest Organics Ltd.

What is Everest Organics share price?

Can I buy Everest Organics shares now?

What is the Dividend Yield of Everest Organics?

What is the Market Cap of Everest Organics?

What are the key metrics to analyse Everest Organics?

What is the 52 Week High and Low of Everest Organics?

What is the trend of Everest Organics share price?